|
1
|
Genome-wide association study reveals genetic risk underlying Parkinson's disease.
|
Nat Genet
|
2009
|
10.34
|
|
2
|
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.
|
J Neurosci
|
2007
|
5.68
|
|
3
|
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.
|
PLoS Genet
|
2012
|
4.27
|
|
4
|
SNCA variants are associated with increased risk for multiple system atrophy.
|
Ann Neurol
|
2009
|
3.55
|
|
5
|
The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.
|
Lancet Neurol
|
2008
|
2.42
|
|
6
|
Multiple regions of alpha-synuclein are associated with Parkinson's disease.
|
Ann Neurol
|
2005
|
2.40
|
|
7
|
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
|
JAMA Neurol
|
2013
|
2.32
|
|
8
|
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.
|
Hum Mol Genet
|
2005
|
2.28
|
|
9
|
Olfactory dysfunction: common in later life and early warning of neurodegenerative disease.
|
Dtsch Arztebl Int
|
2013
|
2.22
|
|
10
|
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.
|
Cell Stem Cell
|
2013
|
2.22
|
|
11
|
Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
|
FASEB J
|
2007
|
1.94
|
|
12
|
Genome-wide association study of intracranial aneurysm identifies three new risk loci.
|
Nat Genet
|
2010
|
1.86
|
|
13
|
Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.
|
Brain
|
2005
|
1.85
|
|
14
|
Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.
|
Clin Cancer Res
|
2012
|
1.74
|
|
15
|
Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair.
|
Hum Mol Genet
|
2009
|
1.59
|
|
16
|
Progression of Parkinson's disease in the clinical phase: potential markers.
|
Lancet Neurol
|
2009
|
1.58
|
|
17
|
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure.
|
Neurology
|
2012
|
1.51
|
|
18
|
Poor effect of guideline based treatment of restless legs syndrome in clinical practice.
|
J Neurol Neurosurg Psychiatry
|
2010
|
1.49
|
|
19
|
SNCA: major genetic modifier of age at onset of Parkinson's disease.
|
Mov Disord
|
2013
|
1.48
|
|
20
|
Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.
|
Ann Neurol
|
2011
|
1.45
|
|
21
|
Transcranial sonography as a diagnostic tool for Parkinson's disease: a pilot study in the city of Rio de Janeiro, Brazil.
|
Arq Neuropsiquiatr
|
2011
|
1.40
|
|
22
|
Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.
|
Neurobiol Dis
|
2008
|
1.39
|
|
23
|
Transcranial brain parenchyma sonography in movement disorders: state of the art.
|
Ultrasound Med Biol
|
2007
|
1.37
|
|
24
|
Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.
|
J Neuroimmunol
|
2007
|
1.34
|
|
25
|
Phosphorylated α-synuclein in Parkinson's disease.
|
Sci Transl Med
|
2012
|
1.29
|
|
26
|
Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
|
Proc Natl Acad Sci U S A
|
2004
|
1.29
|
|
27
|
[11C]PIB binding in Parkinson's disease dementia.
|
Neuroimage
|
2007
|
1.24
|
|
28
|
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
|
Mov Disord
|
2005
|
1.23
|
|
29
|
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7).
|
Hum Mutat
|
2004
|
1.22
|
|
30
|
Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
|
J Biol Chem
|
2011
|
1.19
|
|
31
|
ATP13A2 variants in early-onset Parkinson's disease patients and controls.
|
Mov Disord
|
2009
|
1.12
|
|
32
|
The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect.
|
Neurobiol Dis
|
2011
|
1.12
|
|
33
|
The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease.
|
Mov Disord
|
2011
|
1.10
|
|
34
|
14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.
|
Brain Res Mol Brain Res
|
2002
|
1.09
|
|
35
|
The transcription factor PITX3 is associated with sporadic Parkinson's disease.
|
Neurobiol Aging
|
2007
|
1.09
|
|
36
|
Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
|
Ann Neurol
|
2005
|
1.08
|
|
37
|
Poor trail making test performance is directly associated with altered dual task prioritization in the elderly--baseline results from the TREND study.
|
PLoS One
|
2011
|
1.07
|
|
38
|
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway.
|
Brain
|
2012
|
1.07
|
|
39
|
Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1.
|
PLoS One
|
2013
|
1.04
|
|
40
|
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.
|
J Neural Transm (Vienna)
|
2011
|
1.04
|
|
41
|
Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.
|
Neurobiol Dis
|
2006
|
1.03
|
|
42
|
Specification of 14-3-3 proteins in Lewy bodies.
|
Ann Neurol
|
2003
|
1.02
|
|
43
|
Loss of nocturnal blood pressure fall in various extrapyramidal syndromes.
|
Mov Disord
|
2009
|
1.02
|
|
44
|
Functional relevance of ceruloplasmin mutations in Parkinson's disease.
|
FASEB J
|
2005
|
1.00
|
|
45
|
Multiregional brain iron deficiency in restless legs syndrome.
|
Mov Disord
|
2008
|
1.00
|
|
46
|
Maltose and maltodextrin utilization by Listeria monocytogenes depend on an inducible ABC transporter which is repressed by glucose.
|
PLoS One
|
2010
|
1.00
|
|
47
|
LINGO1 is not associated with Parkinson's disease in German patients.
|
Am J Med Genet B Neuropsychiatr Genet
|
2010
|
0.99
|
|
48
|
Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis.
|
J Pathol
|
2010
|
0.99
|
|
49
|
GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study.
|
Mov Disord
|
2014
|
0.99
|
|
50
|
Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome.
|
Mov Disord
|
2007
|
0.99
|
|
51
|
Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis.
|
J Neurol
|
2009
|
0.96
|
|
52
|
The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein--implications for Parkinson's disease.
|
FASEB J
|
2007
|
0.96
|
|
53
|
Impaired trunk stability in individuals at high risk for Parkinson's disease.
|
PLoS One
|
2012
|
0.95
|
|
54
|
Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
|
J Alzheimers Dis
|
2011
|
0.94
|
|
55
|
Characterizing POLG ataxia: clinics, electrophysiology and imaging.
|
Cerebellum
|
2012
|
0.94
|
|
56
|
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.
|
Parkinsonism Relat Disord
|
2008
|
0.94
|
|
57
|
Clinical and dual-tasking aspects in frequent and infrequent fallers with progressive supranuclear palsy.
|
Mov Disord
|
2010
|
0.93
|
|
58
|
Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases.
|
Mov Disord
|
2010
|
0.92
|
|
59
|
Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease.
|
Parkinsons Dis
|
2011
|
0.91
|
|
60
|
Apoptosis is not required for acantholysis in pemphigus vulgaris.
|
Am J Physiol Cell Physiol
|
2008
|
0.91
|
|
61
|
Predictive value of transcranial sonography in the diagnosis of Parkinson's disease.
|
Mov Disord
|
2006
|
0.91
|
|
62
|
Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
|
Neuroimage
|
2003
|
0.90
|
|
63
|
Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
|
J Neural Transm (Vienna)
|
2009
|
0.90
|
|
64
|
Aging-related cortical reorganization of verbal fluency processing: a functional near-infrared spectroscopy study.
|
Neurobiol Aging
|
2012
|
0.90
|
|
65
|
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.
|
PLoS One
|
2013
|
0.90
|
|
66
|
Analysis of ACTA2 in European Moyamoya disease patients.
|
Eur J Paediatr Neurol
|
2010
|
0.90
|
|
67
|
Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.
|
Eur Radiol
|
2011
|
0.89
|
|
68
|
Transcranial sonography findings related to non-motor features of Parkinson's disease.
|
J Neurol Sci
|
2009
|
0.89
|
|
69
|
Producing reverse phase protein microarrays from formalin-fixed tissues.
|
Methods Mol Biol
|
2011
|
0.89
|
|
70
|
uPA and PAI-1-Related Signaling Pathways Differ between Primary Breast Cancers and Lymph Node Metastases.
|
Transl Oncol
|
2012
|
0.89
|
|
71
|
Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism.
|
Mov Disord
|
2010
|
0.89
|
|
72
|
Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
|
Mov Disord
|
2008
|
0.88
|
|
73
|
Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
|
Mov Disord
|
2009
|
0.88
|
|
74
|
Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.
|
Mov Disord
|
2011
|
0.88
|
|
75
|
Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse.
|
Mov Disord
|
2002
|
0.87
|
|
76
|
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD.
|
Neuroepidemiology
|
2015
|
0.87
|
|
77
|
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.
|
PLoS One
|
2012
|
0.87
|
|
78
|
The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.
|
J Alzheimers Dis
|
2010
|
0.87
|
|
79
|
Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.87
|
|
80
|
Retinal nerve fiber layer loss in multiple system atrophy.
|
Mov Disord
|
2011
|
0.87
|
|
81
|
No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort.
|
Neurobiol Aging
|
2009
|
0.86
|
|
82
|
Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
|
J Alzheimers Dis
|
2010
|
0.86
|
|
83
|
Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes.
|
Cell Tissue Res
|
2010
|
0.86
|
|
84
|
Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
|
Neurobiol Aging
|
2009
|
0.85
|
|
85
|
Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.
|
Childs Nerv Syst
|
2010
|
0.85
|
|
86
|
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues.
|
Histopathology
|
2012
|
0.85
|
|
87
|
Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients.
|
J Alzheimers Dis
|
2013
|
0.85
|
|
88
|
Risk factors and prodromal markers and the development of Parkinson's disease.
|
J Neurol
|
2013
|
0.85
|
|
89
|
Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease.
|
Arch Neurol
|
2011
|
0.84
|
|
90
|
Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.
|
J Neural Transm (Vienna)
|
2008
|
0.84
|
|
91
|
Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients.
|
Virchows Arch
|
2010
|
0.84
|
|
92
|
Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.
|
Mov Disord
|
2006
|
0.84
|
|
93
|
Parkinson's disease and dementia: a longitudinal study (DEMPARK).
|
Neuroepidemiology
|
2011
|
0.84
|
|
94
|
Effect of genetic variation in Kv1.3 on olfactory function.
|
Diabetes Metab Res Rev
|
2009
|
0.84
|
|
95
|
Genetics and iron in the systems biology of Parkinson's disease and some related disorders.
|
Neurochem Int
|
2012
|
0.84
|
|
96
|
Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
|
J Alzheimers Dis
|
2011
|
0.84
|
|
97
|
Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound.
|
Ultrasound Med Biol
|
2010
|
0.84
|
|
98
|
Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.84
|
|
99
|
Autonomic dysfunction in patients with progressive supranuclear palsy.
|
Mov Disord
|
2008
|
0.84
|
|
100
|
Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes.
|
Mov Disord
|
2010
|
0.84
|
|
101
|
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis.
|
Alzheimers Dement
|
2010
|
0.84
|
|
102
|
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.
|
PLoS One
|
2012
|
0.83
|
|
103
|
Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients.
|
J Neural Transm (Vienna)
|
2009
|
0.83
|
|
104
|
Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease.
|
J Neural Transm (Vienna)
|
2014
|
0.83
|
|
105
|
Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
|
J Neurol
|
2007
|
0.83
|
|
106
|
Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients.
|
Acta Neurochir (Wien)
|
2010
|
0.83
|
|
107
|
Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.
|
PLoS One
|
2013
|
0.83
|
|
108
|
Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging.
|
J Neurol Neurosurg Psychiatry
|
2013
|
0.83
|
|
109
|
Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
|
Neuroepidemiology
|
2013
|
0.82
|
|
110
|
Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation.
|
J Neurol
|
2008
|
0.82
|
|
111
|
Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.
|
J Neurol
|
2004
|
0.82
|
|
112
|
Decreased α-synuclein serum levels in patients with Lewy body dementia compared to Alzheimer's disease patients and control subjects.
|
Dement Geriatr Cogn Disord
|
2011
|
0.82
|
|
113
|
Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.
|
Neurosci Lett
|
2006
|
0.82
|
|
114
|
Early diagnosis of Parkinson's disease.
|
Int Rev Neurobiol
|
2010
|
0.82
|
|
115
|
Parenchymal imaging in movement disorders.
|
Front Neurol Neurosci
|
2014
|
0.81
|
|
116
|
How precise are activities of daily living scales for the diagnosis of Parkinson's disease dementia? A pilot study.
|
Parkinsonism Relat Disord
|
2012
|
0.81
|
|
117
|
Lowered serum amyloid-β1-42 autoantibodies in individuals with lifetime depression.
|
J Alzheimers Dis
|
2012
|
0.81
|
|
118
|
Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.
|
Curr Neurol Neurosci Rep
|
2015
|
0.80
|
|
119
|
The significance of GBA for Parkinson's disease.
|
J Inherit Metab Dis
|
2014
|
0.80
|
|
120
|
Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice.
|
Am J Pathol
|
2010
|
0.80
|
|
121
|
Mutation analysis of the neurofilament M gene in Parkinson's disease.
|
Neurosci Lett
|
2003
|
0.80
|
|
122
|
A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.
|
J Neural Transm (Vienna)
|
2009
|
0.80
|
|
123
|
Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's disease.
|
J Neurol
|
2012
|
0.80
|
|
124
|
Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.
|
J Neural Transm (Vienna)
|
2012
|
0.80
|
|
125
|
No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.
|
Neurobiol Dis
|
2009
|
0.80
|
|
126
|
The regional distribution of T2-relaxation times in MR images of the substantia nigra and crus cerebri.
|
Neuroradiology
|
2009
|
0.80
|
|
127
|
Sonographic substantia nigra hypoechogenicity in polyneuropathy and restless legs syndrome.
|
Mov Disord
|
2009
|
0.80
|
|
128
|
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
|
Mov Disord
|
2011
|
0.80
|
|
129
|
Friedreich ataxia: dysarthria profile and clinical data.
|
Cerebellum
|
2013
|
0.80
|
|
130
|
Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach.
|
Int J Alzheimers Dis
|
2012
|
0.79
|
|
131
|
Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.
|
J Neural Transm (Vienna)
|
2009
|
0.79
|
|
132
|
In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
|
J Neural Transm (Vienna)
|
2011
|
0.79
|
|
133
|
Sonographic abnormalities of brainstem structures in restless legs syndrome.
|
Sleep Med
|
2007
|
0.79
|
|
134
|
Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease.
|
Dement Geriatr Cogn Disord
|
2012
|
0.79
|
|
135
|
Biomarkers for PD: How can we approach complexity?
|
Neurology
|
2013
|
0.78
|
|
136
|
Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.
|
Dement Geriatr Cogn Disord
|
2007
|
0.78
|
|
137
|
Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
|
Mov Disord
|
2012
|
0.78
|
|
138
|
Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease.
|
J Neurol
|
2013
|
0.78
|
|
139
|
Analysis of TGFB1 in European and Japanese Moyamoya disease patients.
|
Eur J Med Genet
|
2012
|
0.78
|
|
140
|
Transcranial sonography in the premotor diagnosis of Parkinson's disease.
|
Int Rev Neurobiol
|
2010
|
0.78
|
|
141
|
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.
|
CNS Drugs
|
2014
|
0.78
|
|
142
|
Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers.
|
Parkinsonism Relat Disord
|
2006
|
0.78
|
|
143
|
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.
|
Acta Neuropathol
|
2014
|
0.78
|
|
144
|
Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy.
|
Graefes Arch Clin Exp Ophthalmol
|
2012
|
0.77
|
|
145
|
Stepwise isolation of human peripheral erythrocytes, T lymphocytes, and monocytes for blood cell proteomics.
|
Proteomics Clin Appl
|
2012
|
0.77
|
|
146
|
6-Hydroxydopamine leads to T2 hyperintensity, decreased claudin-3 immunoreactivity and altered aquaporin 4 expression in the striatum.
|
Behav Brain Res
|
2012
|
0.77
|
|
147
|
Evaluation of the ventricular system in children using transcranial ultrasound: reference values for routine diagnostics.
|
Ultrasound Med Biol
|
2004
|
0.77
|
|
148
|
Hand function is impaired in healthy older adults at risk of Parkinson's disease.
|
J Neural Transm (Vienna)
|
2014
|
0.76
|
|
149
|
Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
|
Mov Disord
|
2007
|
0.76
|
|
150
|
Transcranial sonography reveals cerebellar, nigral, and forebrain abnormalities in Friedreich's ataxia.
|
Neurodegener Dis
|
2011
|
0.76
|
|
151
|
Parkinson's disease with and without preceding essential tremor-similar phenotypes: a pilot study.
|
J Neurol
|
2014
|
0.76
|
|
152
|
Substantia nigra hyperechogenicity in healthy controls: a [¹⁸Fluoro] Dopa-PET follow-up study.
|
J Neurol
|
2013
|
0.76
|
|
153
|
Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease.
|
Neurogenetics
|
2010
|
0.76
|
|
154
|
Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.
|
Cerebellum
|
2011
|
0.76
|
|
155
|
Autonomic dysfunction in different subtypes of multiple system atrophy.
|
Mov Disord
|
2008
|
0.76
|
|
156
|
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany.
|
Sleep Med
|
2013
|
0.76
|
|
157
|
No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's disease.
|
Mov Disord
|
2013
|
0.75
|
|
158
|
Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra.
|
Neurosci Lett
|
2003
|
0.75
|
|
159
|
Nutrition and the risk for Parkinson's disease: review of the literature.
|
J Neural Transm (Vienna)
|
2008
|
0.75
|
|
160
|
Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 Cases.
|
Sleep Disord
|
2011
|
0.75
|
|
161
|
High-throughput homogeneous mass cleave assay technology for the diagnosis of autosomal recessive Parkinson's disease.
|
J Mol Diagn
|
2008
|
0.75
|
|
162
|
Therapeutic strategies for Parkinson's disease based on data derived from genetic research.
|
J Neurol
|
2003
|
0.75
|
|
163
|
In reply.
|
Dtsch Arztebl Int
|
2013
|
0.75
|
|
164
|
No association between NOD2 variants and Parkinson's disease.
|
Mov Disord
|
2012
|
0.75
|
|
165
|
Role of transcranial ultrasound in the diagnosis of movement disorders.
|
Neuroimaging Clin N Am
|
2010
|
0.75
|
|
166
|
Quantitative motor assessment of dyskinesias in Parkinson's disease.
|
J Neural Transm (Vienna)
|
2015
|
0.75
|
|
167
|
Cerebrotendinous xanthomatosis.
|
Neurology
|
2006
|
0.75
|
|
168
|
Further delineation of the association signal on chromosome 5 from the first whole genome association study in Parkinson's disease.
|
Neurobiol Aging
|
2008
|
0.75
|
|
169
|
Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.
|
J Neurol
|
2014
|
0.75
|
|
170
|
POLG and PEO1 (Twinkle) mutations are infrequent in PSP-like atypical parkinsonism: a preliminary screening study.
|
J Neurol
|
2012
|
0.75
|
|
171
|
Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive Subtypes.
|
Neurodegener Dis
|
2017
|
0.75
|
|
172
|
Self estimated quality of life in monogenetic Parkinson's disease.
|
Mov Disord
|
2010
|
0.75
|
|
173
|
Preface. Summary of content--TCS in the diagnosis of movement disorders.
|
Int Rev Neurobiol
|
2010
|
0.75
|
|
174
|
The relation of SMI and the VSEP in a risk sample for neurodegenerative disorders.
|
J Neural Transm (Vienna)
|
2014
|
0.75
|